Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer. - Chatzipli, Aikaterini; Bonnefoi, Hervé; MacGrogan, Gaetan; Sentis, Julie; Cameron, David; Poncet, Coralie; EORTC 10994/BIG 1-00 Consortium; Abadie-Lacourtoisie, Sophie; Bodmer, Alexandre; Brain, Etienne; Cufer, Tanja; Campone, Mario; et al. (British Journal of Cancer, 2021)